Android app Apple app link

Ionis Pharmaceuticals, Inc. (IONS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$34.10

south_east
-$0.71 (-2.04%)
Day's range
$33.92
Day's range
$35.15

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/09/2024 Guggenheim Debjit Chattopadhyay $65.00 $37.80   71.96%
08/02/2024 BMO Capital Kostas Biliouris $60.00 $51.32   16.91%
07/24/2024 Leerink Partners Mani Foroohar $62.00 $51.86   19.55%
07/22/2024 Jefferies Akash Tewari $77.00 $50.61   52.14%
07/22/2024 Goldman Sachs Salveen Richter $33.00 $50.61   -34.8%
07/16/2024 Jefferies Akash Tewari $75.00 $49.84   50.48%
06/27/2024 Stifel Nicolaus Paul Matteis $53.00 $47.70   11.11%
06/17/2024 RBC Capital Luca Issi $70.00 $40.63   72.29%
06/14/2024 Tudor Pickering William Pickering $44.00 $41.12   7%
05/17/2024 BMO Capital Kostas Biliouris $67.00 $36.84   81.87%
06/21/2022 Piper Sandler Do Kim $55.00 $37.56   46.43%
02/23/2022 Needham Joseph Stringer $60.00 $32.49   84.67%
02/23/2022 RBC Capital Luca Issi $67.00 $32.49   106.22%
01/31/2022 Bank of America Securities Jason Gerberry $30.00 $31.51   -4.79%
11/03/2021 Barclays Gena Wang $33.00 $34.63   -4.71%
10/17/2021 Laidlaw Yale Jen $68.00 $30.25   124.79%
05/09/2021 UBS Esther Rajavelu $37.50 $36.24   3.48%
05/04/2021 Oppenheimer Kevin DeGeeter $63.00 $39.89   57.93%

Ionis Pharmaceuticals, Inc. FAQ's

Ionis Pharmaceuticals, Inc. has been rated by research analysts at Guggenheim, BMO Capital, Leerink Partners, Jefferies, Goldman Sachs, Stifel Nicolaus in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.